NRF2 and STAT3: friends or foes in carcinogenesis?

Abstract NRF2 is a transcription factor that plays a pivotal role in carcinogenesis, also through the interaction with several pro-survival pathways. NRF2 controls the transcription of detoxification enzymes and a variety of other molecules impinging in several key biological processes. This perspec...

Full description

Bibliographic Details
Main Authors: Andrea Arena, Maria Anele Romeo, Rossella Benedetti, Maria Saveria Gilardini Montani, Roberta Santarelli, Roberta Gonnella, Gabriella D’Orazi, Mara Cirone
Format: Article
Language:English
Published: Springer 2023-03-01
Series:Discover Oncology
Subjects:
Online Access:https://doi.org/10.1007/s12672-023-00644-z
_version_ 1797853698359033856
author Andrea Arena
Maria Anele Romeo
Rossella Benedetti
Maria Saveria Gilardini Montani
Roberta Santarelli
Roberta Gonnella
Gabriella D’Orazi
Mara Cirone
author_facet Andrea Arena
Maria Anele Romeo
Rossella Benedetti
Maria Saveria Gilardini Montani
Roberta Santarelli
Roberta Gonnella
Gabriella D’Orazi
Mara Cirone
author_sort Andrea Arena
collection DOAJ
description Abstract NRF2 is a transcription factor that plays a pivotal role in carcinogenesis, also through the interaction with several pro-survival pathways. NRF2 controls the transcription of detoxification enzymes and a variety of other molecules impinging in several key biological processes. This perspective will focus on the complex interplay of NRF2 with STAT3, another transcription factor often aberrantly activated in cancer and driving tumorigenesis as well as immune suppression. Both NRF2 and STAT3 can be regulated by ER stress/UPR activation and their cross-talk influences and is influenced by autophagy and cytokines, contributing to shape the microenvironment, and both control the execution of DDR, also by regulating the expression of HSPs. Given the importance of these transcription factors, more investigations aimed at better elucidating the outcome of their networking could help to discover new and more efficacious strategies to fight cancer.
first_indexed 2024-04-09T19:54:55Z
format Article
id doaj.art-15bcc674e8b744f682571bc4ce72aa38
institution Directory Open Access Journal
issn 2730-6011
language English
last_indexed 2024-04-09T19:54:55Z
publishDate 2023-03-01
publisher Springer
record_format Article
series Discover Oncology
spelling doaj.art-15bcc674e8b744f682571bc4ce72aa382023-04-03T05:31:49ZengSpringerDiscover Oncology2730-60112023-03-0114111010.1007/s12672-023-00644-zNRF2 and STAT3: friends or foes in carcinogenesis?Andrea Arena0Maria Anele Romeo1Rossella Benedetti2Maria Saveria Gilardini Montani3Roberta Santarelli4Roberta Gonnella5Gabriella D’Orazi6Mara Cirone7Department of Experimental Medicine, Sapienza University of RomeDepartment of Experimental Medicine, Sapienza University of RomeDepartment of Experimental Medicine, Sapienza University of RomeDepartment of Experimental Medicine, Sapienza University of RomeDepartment of Experimental Medicine, Sapienza University of RomeDepartment of Experimental Medicine, Sapienza University of RomeDepartment of Neurosciences, Imaging and Clinical Sciences, University “G. D’Annunzio”Department of Experimental Medicine, Sapienza University of RomeAbstract NRF2 is a transcription factor that plays a pivotal role in carcinogenesis, also through the interaction with several pro-survival pathways. NRF2 controls the transcription of detoxification enzymes and a variety of other molecules impinging in several key biological processes. This perspective will focus on the complex interplay of NRF2 with STAT3, another transcription factor often aberrantly activated in cancer and driving tumorigenesis as well as immune suppression. Both NRF2 and STAT3 can be regulated by ER stress/UPR activation and their cross-talk influences and is influenced by autophagy and cytokines, contributing to shape the microenvironment, and both control the execution of DDR, also by regulating the expression of HSPs. Given the importance of these transcription factors, more investigations aimed at better elucidating the outcome of their networking could help to discover new and more efficacious strategies to fight cancer.https://doi.org/10.1007/s12672-023-00644-zNRF2STAT3p62/SQSTM1CytokinesDDR
spellingShingle Andrea Arena
Maria Anele Romeo
Rossella Benedetti
Maria Saveria Gilardini Montani
Roberta Santarelli
Roberta Gonnella
Gabriella D’Orazi
Mara Cirone
NRF2 and STAT3: friends or foes in carcinogenesis?
Discover Oncology
NRF2
STAT3
p62/SQSTM1
Cytokines
DDR
title NRF2 and STAT3: friends or foes in carcinogenesis?
title_full NRF2 and STAT3: friends or foes in carcinogenesis?
title_fullStr NRF2 and STAT3: friends or foes in carcinogenesis?
title_full_unstemmed NRF2 and STAT3: friends or foes in carcinogenesis?
title_short NRF2 and STAT3: friends or foes in carcinogenesis?
title_sort nrf2 and stat3 friends or foes in carcinogenesis
topic NRF2
STAT3
p62/SQSTM1
Cytokines
DDR
url https://doi.org/10.1007/s12672-023-00644-z
work_keys_str_mv AT andreaarena nrf2andstat3friendsorfoesincarcinogenesis
AT mariaaneleromeo nrf2andstat3friendsorfoesincarcinogenesis
AT rossellabenedetti nrf2andstat3friendsorfoesincarcinogenesis
AT mariasaveriagilardinimontani nrf2andstat3friendsorfoesincarcinogenesis
AT robertasantarelli nrf2andstat3friendsorfoesincarcinogenesis
AT robertagonnella nrf2andstat3friendsorfoesincarcinogenesis
AT gabrielladorazi nrf2andstat3friendsorfoesincarcinogenesis
AT maracirone nrf2andstat3friendsorfoesincarcinogenesis